@article {Bai200287, author = {Chunxue Bai and Sanjay H. Chotirmall and Jordi Rello and George A. Alba and Leo C. Ginns and Jerry A. Krishnan and Robert Rogers and Elisabeth Bendstrup and Pierre-Regis Burgel and James D. Chalmers and Abigail Chua and Kristina A. Crothers and Abhijit Duggal and Yeon Wook Kim and John G. Laffey and Carlos M. Luna and Michael S. Niederman and Ganesh Raghu and Julio A. Ramirez and Jordi Riera and Oriol Roca and Maximiliano Tamae-Kakazu and Antoni Torres and Richard R. Watkins and Miriam Barrecheguren and Mirko Belliato and Hassan A. Chami and Rongchang Chen and Gustavo A. Cortes-Puentes and Charles Delacruz and Margaret M. Hayes and Leo M.A. Heunks and Steven R. Holets and Catherine L. Hough and Sugeet Jagpal and Kyeongman Jeon and Takeshi Johkoh and May M. Lee and Janice Liebler and Gerry N. McElvaney and Ari Moskowitz and Richard A. Oeckler and I{\~n}igo Ojanguren and Anthony O{\textquoteright}Regan and Mathias W. Pletz and Chin Kook Rhee and Marcus J. Schultz and Enrico Storti and Charlie Strange and Carey C. Thomson and Francesca J. Torriani and Xun Wang and Wim Wuyts and Tao Xu and Dawei Yang and Ziqiang Zhang and Kevin C. Wilson}, title = {Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)}, volume = {29}, number = {157}, elocation-id = {200287}, year = {2020}, doi = {10.1183/16000617.0287-2020}, publisher = {European Respiratory Society}, abstract = {Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby improving outcomes and facilitating future research.Methods An International Task Force was composed and agreement regarding courses of action was measured using the Convergence of Opinion on Recommendations and Evidence (CORE) process. 70\% agreement was necessary to make a consensus suggestion.Results The Task Force made consensus suggestions to treat patients with acute COVID-19 pneumonia with remdesivir and dexamethasone but suggested against hydroxychloroquine except in the context of a clinical trial; these are revisions of prior suggestions resulting from the interim publication of several randomised trials. It also suggested that COVID-19 patients with a venous thromboembolic event be treated with therapeutic anticoagulant therapy for 3 months. The Task Force was unable to reach sufficient agreement to yield consensus suggestions for the post-hospital care of COVID-19 survivors. The Task Force fell one vote shy of suggesting routine screening for depression, anxiety and post-traumatic stress disorder.Conclusions The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.For patients with acute COVID-19 pneumonia who require oxygen support, the International Task Force made suggestions for remdesivir and dexamethasone, but against hydroxychloroquine. Post-discharge management of COVID-19 survivors is a research priority. https://bit.ly/32B96uI}, issn = {0905-9180}, URL = {https://err.ersjournals.com/content/29/157/200287}, eprint = {https://err.ersjournals.com/content/29/157/200287.full.pdf}, journal = {European Respiratory Review} }